167 results on '"Jansen, Marnix"'
Search Results
2. The co-evolution of the genome and epigenome in colorectal cancer
3. Phenotypic plasticity and genetic control in colorectal cancer evolution
4. Immunosuppressive niche engineering at the onset of human colorectal cancer
5. Evidence for hypoxia increasing the tempo of evolution in glioblastoma
6. Abstract 4539: Tumor evolution and immune microenvironment dynamics define response to neoadjuvant treatment of esophageal adenocarcinoma
7. The Barrett’s Gland in Phenotype Space
8. A digital pathology workflow for the segmentation and classification of gastric glands: Study of gastric atrophy and intestinal metaplasia cases
9. Pan-cancer analysis of the extent and consequences of intratumor heterogeneity
10. Mo1164: UTILISATION OF THE CYTOSPONGE DEVICE AS A TOOL FOR RISK STRATIFICATION IN PATIENTS WITH BARRETT'S OESOPHAGUS WHO ARE OVERDUE ENDOSCOPIC SURVEILLANCE DUE TO THE COVID-19 PANDEMIC
11. Clonal Transitions and Phenotypic Evolution in Barrett’s Esophagus
12. Analysis of LKB1 mutations and other molecular alterations in pancreatic acinar cell carcinoma
13. Tertiary lymphoid structures (TLS) identification and density assessment on H&E-stained digital slides of lung cancer
14. The natural history of low‐grade dysplasia in Barrett's esophagus and risk factors for progression
15. Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions
16. One-Year Morbidity Following Videoscopic Inguinal Lymphadenectomy for Stage III Melanoma
17. Stain-free identification of tissue pathology using a generative adversarial network to infer nanomechanical signatures
18. 253e IMMUNE EDITING IN THE INVASIVE MARGIN AND NODE DEPOSITS OF COLORECTAL CANCER SELECTS FOR CELLULAR NEIGHBOURHOODS ENRICHED IN PDL1+ CANCER CELLS
19. Tu1269 DEEP GLAND PHENOTYPING IN BARRETT'S ESOPHAGUS GLANDS REVEALS POTENTIAL BIOMARKERS OF CANCER RISK
20. Tu1286 LONG-TERM OUTCOMES OF PATIENTS FOLLOWING ENDOSCOPIC RESECTION FOR HIGH RISK T1A AND T1B OESOPHAGEAL ADENOCARCINOMA
21. Tu1280 GLAND PHENOTYPIC DIVERSITY OVER TIME AND SPACE AS A PREDICTOR OF PROGRESSION TO DYSPLASIA IN BARRETT'S ESOPHAGUS
22. Tu1277 UTILISATION OF THE CYTOSPONGE DEVICE AS A TOOL FOR NON-ENDOSCOPIC SURVEILLANCE IN PATIENTS WITH BARRETT'S OESOPHAGUS
23. 225 MITOTIC AGE OF NON-DYSPLASTIC BARRETT'S ESOPHAGUS DEFINES RISK OF PROGRESSION TO ESOPHAGEAL ADENOCARCINOMA USING A NOVEL TARGETED ALLELE SPECIFIC METHYLATION SEQUENCING ARRAY
24. Recent advances in the detection and management of early gastric cancer and its precursors
25. Mo1171 ARTIFICIAL INTELLIGENCE (AI) BASED ANALYSIS OF INESTINALIZATION MARKERS SUPPORTS NON-GOBLET CELL PATHWAY FOR THE DEVLOPMENT OF HIGH GRADE DYSPLASIA (HGD) IN BARRETT'S ESOPHAGUS
26. 30 TRACING SPATIAL CLONAL EVOLUTION OF INTESTINAL METAPLASIA IN THE CHRONICALLY INFLAMED STOMACH, A QUANTITATIVE MODEL OF PRE-TUMOUR PROGRESSION.
27. VEROnA Protocol: A Pilot, Open-Label, Single-Arm, Phase 0, Window-of-Opportunity Study of Vandetanib-Eluting Radiopaque Embolic Beads (BTG-002814) in Patients With Resectable Liver Malignancies
28. Histopathologist Features Predictive of Diagnostic Concordance at Expert Level Amongst a Large International Sample of Pathologists Diagnosing Barrett’s Dysplasia Using Digital Pathology
29. Undifferentiated sarcomas develop through distinct evolutionary pathways
30. Recent advances in the detection and management of early gastric cancer and its precursors.
31. Evolution of oesophageal adenocarcinoma from metaplastic columnar epithelium without goblet cells in Barrett's oesophagus
32. Evolutionary history of human colitis-associated colorectal cancer
33. Accuracy of endoscopic staging and targeted biopsies for routine gastric intestinal metaplasia and gastric atrophy evaluation study protocol of a prospective, cohort study: the estimate study
34. Quality indicators for Barrett’s endotherapy (QBET): UK consensus statements for patients undergoing endoscopic therapy for Barrett’s neoplasia
35. Sa1160 – The Natural History of Low Grade Dysplasia in Patients with Barrett's Esophagus: 12 Year Retrospective Analysis from a Tertiary Centre
36. Quantification of Crypt and Stem Cell Evolution in the Normal and Neoplastic Human Colon
37. 781 – Quantifying Evolution of Early Dysplastic Lesions in Ulcerative Colitis Predicts Future Colorectal Cancer Risk
38. Sa1140 – Histopathologist Features Predictive of Diagnostic Concordance At Expert Level Amongst a Large International Sample of Pathologists Diagnosing Barrett's Dysplasia
39. Undifferentiated Sarcomas Develop through Distinct Evolutionary Pathways
40. Risk of lymph node metastases in patients with T1b oesophageal adenocarcinoma: A retrospective single centre experience
41. Quality indicators for Barrett's endotherapy (QBeT): UK consensus statements for patients undergoing endoscopic therapy for Barrett's neoplasia.
42. Abstract 5368: The evolutionary history of human colitis-associated colorectal cancer
43. The evolving role of endoscopy in the diagnosis of premalignant gastric lesions
44. Tu1112 - What Makes an Expert Barrett's Pathologist? - Histopathologist Features Predictive of Diagnostic Concordance at Expert Level Amongst a Large International Sample of Pathologists Diagnosing Barrett's Dysplasia
45. 335 - Lineage Tracing in Barrett's Esophagus Reveals both its Origins and Evolution and Suggests that Gland Diversity may be an Important Biomarker for the Progression to Dysplasia in Patients
46. Insights Into the Pathophysiology of Esophageal Adenocarcinoma
47. Robust RNA-based in situ mutation detection delineates colorectal cancer subclonal evolution
48. Vitamin D3 suppresses morphological evolution of the cribriform cancerous phenotype
49. LKB1 and AMPK family signaling: the intimate link between cell polarity and energy metabolism
50. Clonal Interactions as Mechanisms of Polyclonality in Colorectal Adenomas
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.